Literature DB >> 6248085

Clinical experience with a new steroid muscle relaxant: pipecurium bromide.

A A Bunjatjan, V I Miheev.   

Abstract

Experience gained in applying to 102 surgery patients a steroid muscle relaxant 2 beta,16 beta-bis-(4'-dimethyl-1'-piperazino)-3 alpha,17 beta-diacetoxy-5 alpha-androstane dibromide (pipecurium bromide, RGH 1106, Arduan) is reported. Pipercurium bromide proved to be a potent muscle relaxant with a medium duration of action. It can successfully be applied for intubation. Residual relaxation can be antagonized with neostigmine. Pipecurium bromide did not influence circulation, is free of side effects and can be applied in anaesthesiologically high-risk patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248085

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Pharmacokinetics and cardiovascular dynamics of pipecuronium bromide during coronary artery surgery.

Authors:  J M Wierda; G F Karliczek; R H Vandenbrom; I Pinto; U W Kersten-Kleef; D K Meijer; S Agoston
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

2.  Neuromuscular and cardiovascular effects of pipecuronium.

Authors:  F F Foldes; H Nagashima; H D Nguyen; D Duncalf; P L Goldiner
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

Review 3.  Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.

Authors:  Michael J Grant; Roy S Herbst; Sarah B Goldberg
Journal:  Nat Rev Clin Oncol       Date:  2021-06-24       Impact factor: 66.675

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.